SCL Science Balance Sheet Health
Financial Health criteria checks 3/6
SCL Science has a total shareholder equity of ₩16.8B and total debt of ₩4.0B, which brings its debt-to-equity ratio to 23.8%. Its total assets and total liabilities are ₩23.4B and ₩6.6B respectively.
Key information
23.8%
Debt to equity ratio
₩3.99b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩3.40b |
| Equity | ₩16.80b |
| Total liabilities | ₩6.59b |
| Total assets | ₩23.39b |
Financial Position Analysis
Short Term Liabilities: A246960's short term assets (₩6.4B) exceed its short term liabilities (₩1.7B).
Long Term Liabilities: A246960's short term assets (₩6.4B) exceed its long term liabilities (₩4.9B).
Debt to Equity History and Analysis
Debt Level: A246960's net debt to equity ratio (3.5%) is considered satisfactory.
Reducing Debt: A246960's debt to equity ratio has increased from 5% to 23.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A246960 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: A246960 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 9.7% each year